Finland· FI-REL-REL39825

Atripla

A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenz + emtricitabine + tenofovir disoproxil fumarate, registered in Finland by Orifarm Oy. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedAtriplaATCJ05AR06REGISTER NO.FI-REL-REL39825PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Efavirenz + Emtricitabine + Tenofovir disoproxil fumarate
Manufacturer
Orifarm Oy
Country
Finland (FI)
ATC code
J05AR06
ATC class
Emtricitabine, tenofovir disoproxil and efavirenz
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Emtricitabine, tenofovir disoproxil and efavirenz in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine, tenofovir disoproxil and efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
  • Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
  • Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
  • Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
  • France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
  • United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
  • Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
  • Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
  • Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
  • Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
  • Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
  • Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
  • Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
  • Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
  • Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
  • Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3dc188f0-6891-4ef8-85f9-5768fcf5da40
GET /v1/drugs/3dc188f0-6891-4ef8-85f9-5768fcf5da40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti, kalvopäällysteinen",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": "600 mg / 200 mg / 245 mg",
  "atc_label": "emtrisitabiini, tenofoviiridisoproksiili ja efavirentsi",
  "ma_number": null,
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": "EU/1/07/430/001",
  "fimea_rel_id": "REL39825",
  "authorised_at": "2011-03-28"
}

See everything about emtricitabine, tenofovir disoproxil and efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.